4.7 Article

Warm, Humid, and High Sun Exposure Climates Are Associated with Poorly Controlled Eczema: PEER (Pediatric Eczema Elective Registry) Cohort, 2004-2012

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 134, Issue 1, Pages 51-57

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2013.274

Keywords

-

Categories

Funding

  1. NIH [AR056755]
  2. Valeant Pharmaceuticals through the University of Pennsylvania

Ask authors/readers for more resources

Anecdotal reports of children experiencing eczema flares during winter and summer months along with global variation in eczema prevalence has fueled speculation that climate may modulate disease activity. The aim of this study was to determine whether long-term weather patterns affect the severity and persistence of eczema symptoms in children. We performed a prospective cohort study of US children (N=5,595) enrolled in PEER (Pediatric Eczema Elective Registry) between 2004 and 2012 to evaluate the effect of climate (daily temperature, daily sun exposure, daily humidity) on the severity of eczema symptoms. Odds ratios (ORs) were calculated for the patient-evaluated outcome of disease control. Multivariate logistic regression modeling adjusting for gender, race, income, and topical medication use demonstrated that higher temperature (OR= 0.90, 95% confidence interval (Cl): 0.87-0.93, P < 0.001) and increased sun exposure (OR= 0.93, 95% Cl: 0.89-0.98, P=0.009) were associated with poorly controlled eczema. Higher humidity (OR= 0.90, 95% Cl: 0.812-0.997, P=0.04) was also associated with poorly controlled disease, but the statistical significance of this association was lost in our multivariate analysis (P = 0.44).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Dermatology

Ambient ultraviolet radiation and major salivary gland cancer in the United States

Zhi-Ming Mai, Michael R. Sargen, Rochelle E. Curtis, Ruth M. Pfeiffer, Margaret A. Tucker, Elizabeth K. Cahoon

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Review Oncology

Sebaceous Carcinoma Epidemiology and Genetics: Emerging Concepts and Clinical Implications for Screening, Prevention, and Treatment

Michael R. Sargen, Gabriel J. Starrett, Eric A. Engels, Elizabeth K. Cahoon, Margaret A. Tucker, Alisa M. Goldstein

Summary: Sebaceous carcinoma is an aggressive skin cancer with varying survival rates based on disease severity. Its incidence has been increasing in the United States for decades, with unclear reasons. Recent research has provided new insights into the epidemiology, genetics, and tumor biology of this cancer, as well as evidence of a possible viral etiology.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of CDKN2A and CDK4

Michael R. Sargen, Ruth M. Pfeiffer, David E. Elder, Xiaohong R. Yang, Alisa M. Goldstein, Margaret A. Tucker

Summary: The study evaluated thickness for first primary melanomas diagnosed in melanoma-prone families and found that participation in a longitudinal surveillance program providing skin cancer screening and education about skin self-exams was associated with thinner melanomas for members of melanoma-prone families. The findings support the clinical benefit of screening (physician and self) for this high-risk population.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Editorial Material Oncology

Genotypic vs Phenotypic Risk Assessment for Melanoma

Michael R. Sargen, Margaret A. Tucker

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family

Kevin M. Brown, Mai Xu, Michael Sargen, Hyunbum Jang, Mingzhen Zhang, Tongwu Zhang, Bin Zhu, Kristie Jones, Jung Kim, Laura Mendoza, Nicholas K. Hayward, Margaret A. Tucker, Alisa M. Goldstein, Xiaohong Rose Yang, Douglas R. Stewart, Belynda Hicks, Dario Consonni, Angela C. Pesatori, Maria Concetta Fargnoli, Ketty Peris, Alex Stratigos, Chiara Menin, Paola Ghiorzo, Susana Puig, Eduardo Nagore, Thorkell Andresson, Ruth Nussinov, Donato Calista, Maria Teresa Landi

Summary: A novel NRAS variant was identified in an Italian melanoma-prone family, absent in other populations, influencing signaling pathways differently than other RAS activating alterations. Further investigation into NRAS as a familial melanoma gene is warranted.

FAMILIAL CANCER (2022)

Article Obstetrics & Gynecology

Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists

Jim Z. Mai, Rui Zhang, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Margaret A. Tucker, Cari M. Kitahara, Elizabeth K. Cahoon

Summary: This study found that earlier age at menarche and late age at first birth were associated with an increased incidence rate of melanoma. However, other estrogen-related factors and exogenous hormone use were not significantly associated with melanoma incidence.

HUMAN REPRODUCTION (2022)

Letter Dermatology

Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome

Jessica N. Hatton, Michael R. Sargen, Megan N. Frone, Kelvin C. de Andrade, Sharon A. Savage, Payal P. Khincha

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Dermatology

Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US

Michael R. Sargen, Elizabeth K. Cahoon, Kelly J. Yu, Margaret M. Madeleine, Yun Zeng, Judy R. Rees, Charles F. Lynch, Eric A. Engels

Summary: This study characterized the spectrum of nonkeratinocyte skin cancers and identified risk factors in solid organ transplant recipients. The findings suggest that viruses, UV radiation exposure, and immunosuppression are associated with the development of skin cancer in this population.

JAMA DERMATOLOGY (2022)

Article Oncology

Use of Nonsteroidal Anti-Inflammatory Drugs and Incidence of Melanoma in the United States Radiologic Technologists Study

Jim Z. Mai, Cari M. Kitahara, Michael R. Sargen, Mark P. Little, Bruce H. Alexander, Martha S. Linet, Margaret A. Tucker, Elizabeth K. Cahoon

Summary: This study found no significant association between NSAID use and melanoma risk, even in sun-sensitive subgroups.

CANCER PREVENTION RESEARCH (2022)

Article Dermatology

Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report

Blake E. Vest, Christina L. Harview, Vincent Liu, Brian L. Swick, Kristen G. Berrebi, Shantel Olivares, Mary S. Stone, Michael R. Sargen, Pedram Gerami

Summary: Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described skin tumor with limited cases reported. The tumor is characterized by atypical cells confined to the dermis and subcutis, featuring large vesicular nuclei and abundant eosinophilic cytoplasm. The long-term outcomes of this entity are not yet well-studied, and further research is needed for accurate classification.

JOURNAL OF CUTANEOUS PATHOLOGY (2022)

Article Dermatology

Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy

Yen T. Luu, Qianlai Luo, Marie-Josephe Horner, Meredith Shiels, Eric A. Engels, Michael R. Sargen

Summary: Antiretroviral therapy may alter susceptibility to nonkeratinocyte skin cancers (NKSCs) by improving immunity in people living with HIV. Incidence rates for various NKSCs were calculated and compared with the general population, and risk factors for NKSCs were evaluated. The study found that the risk for most NKSCs was similar to that of the general population during the antiretroviral therapy era, suggesting that people living with HIV without NKSC risk factors may not require intensive skin surveillance.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Oncology

Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers

Michael R. Sargen, Hildur Helgadottir, Xiaohong R. Yang, Mark Harland, Jessica N. Hatton, Kristine Jones, Belynda D. Hicks, Amy Hutchinson, Michael Curry, Margaret A. Tucker, Alisa M. Goldstein, Ruth M. Pfeiffer

Summary: This study found a relationship between CDKN2A germline pathogenic variants (GPV) and transcript alteration (p16/p14ARF) with increased risk of melanoma, pancreatic cancer, head and neck squamous cell carcinoma, and lung cancer. Combining p16 and p14ARF alteration was associated with increased incidence of esophageal cancer and malignant peripheral nerve sheath tumor.

JNCI CANCER SPECTRUM (2022)

Meeting Abstract Dermatology

Second primary cancer risk after diagnosis of melanoma by subtype

Y. Luu, A. Goldstein, M. Sargen

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Meeting Abstract Dermatology

Skin cancer risk in people living with HIV during the antiretroviral therapy era

Y. T. Luu, Q. Luo, M. Horner, M. Shiels, E. Engels, M. Sargen

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

No Data Available